WNK1 and pseudohypoaldosteronism type 2: For example, loss of WNK3 may reduce ischemia-associated brain damage [38], whereas mutations in WNK1 and WNK4 disrupt renal salt uptake to induce pseudohypoaldosteronism type II (PHAII) [14].